Diacylglycerol Kinase-ε: Properties and Biological Roles
Open Access
- 18 October 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 4, 112
Abstract
In mammals there are at least 10 isoforms of diacylglycerol kinases (DGK). All catalyze the phosphorylation of diacylglycerol (DAG) to phosphatidic acid (PA). Among DGK isoforms, DGKε has several unique features. It is the only DGK isoform with specificity for a particular species of DAG, i.e. 1-stearoyl-2-arachidonoyl glycerol. The smallest of all known DGK isoforms, DGKε, is also the only DGK devoid of a regulatory domain. DGKε is the only DGK isoform that has a hydrophobic segment that is predicted to form a transmembrane helix. As the only membrane-bound, constitutively active DGK isoform with exquisite specificity for particular molecular species of DAG, the functional overlap between DGKε and other DGKs is predicted to be minimal. DGKε exhibits specificity for DAG containing the same acyl chains as those found in the lipid intermediates of the phosphatidylinositol-cycle. It has also been shown that DGKε affects the acyl chain composition of phosphatidylinositol in whole cells. It is thus likely that DGKε is responsible for catalyzing one step in the phosphatidylinositol-cycle. Steps of this cycle take place in both the plasma membrane and the endoplasmic reticulum membrane. DGKε is likely present in both of these membranes. DGKε is the only DGK isoform that is associated with a human disease. Indeed, recessive loss-of-function mutations in DGKε cause atypical hemolytic-uremic syndrome (aHUS). This condition is characterized by thrombosis in the small vessels of the kidney. It causes acute renal insufficiency in infancy and most patients develop end-stage renal failure before adulthood. Disease pathophysiology is poorly understood and there is no therapy. There are also data suggesting that DGKε may play a role in epilepsy and Huntington disease. Thus, DGKε has many unique molecular and biochemical properties when compared to all other DGK isoforms. DGKε homologs also contain a number of conserved sequence features that are distinctive characteristics of either the rodents or specific groups of primate homologs. How cells, tissues and organisms harness DGKε’s catalytic prowess remains unclear. The discovery of DGKε’s role in causing aHUS will hopefully boost efforts to unravel the mechanisms by which DGKε dysfunction causes disease.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (9848)
This publication has 112 references indexed in Scilit:
- Recessive mutations in DGKE cause atypical hemolytic-uremic syndromeNature Genetics, 2013
- Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycleFEBS Letters, 2011
- Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy MinimizationBiophysical Journal, 2011
- Study of Arachidonoyl Specificity in Two Enzymes of the PI CycleJournal of Molecular Biology, 2011
- Endocannabinoids and diacylglycerol kinase activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Dramatic Differences in the Roles in Lipid Metabolism of Two Isoforms of Diacylglycerol KinaseBiochemistry, 2008
- Analysis of the Staphylococcus aureus DgkB Structure Reveals a Common Catalytic Mechanism for the Soluble Diacylglycerol KinasesStructure, 2008
- Large‐scale mapping of human protein–protein interactions by mass spectrometryMolecular Systems Biology, 2007
- Taxonomy and function of C1 protein kinase C homology domainsProtein Science, 1997
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993